Prescription Required
Imfinzi 500mg Injection is a prescription medication used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC) and urothelial carcinoma (a form of bladder cancer). It belongs to a class of medications known as immune checkpoint inhibitors and works by enhancing the immune system's ability to target and destroy cancer cells. The active ingredient, Durvalumab, binds to the PD-L1 protein on tumor cells, blocking its interaction with PD-1 receptors, which is a mechanism that cancers use to evade immune detection.
By blocking this interaction, Imfinzi enables the immune system to recognize and attack cancer cells more effectively. Imfinzi has been proven to help in prolonging survival and improving the quality of life for patients suffering from these aggressive cancers.
Liver function should be carefully monitored during Imfinzi treatment, as there may be risks of liver-related side effects. Your doctor may conduct regular liver function tests before and during your treatment.
Patients with kidney problems should consult their doctor before using Imfinzi 500mg Injection. While the medication does not have direct adverse effects on kidney function, your doctor will monitor your kidney health during treatment.
It is generally recommended to limit or avoid alcohol consumption while undergoing treatment with Imfinzi. Alcohol can affect your immune system and overall health, possibly reducing the effectiveness of cancer treatment.
Some people may experience side effects such as dizziness or fatigue. If you experience these symptoms, you should avoid driving or operating machinery until you feel better.
Imfinzi is not recommended during pregnancy unless absolutely necessary. Animal studies have shown that Durvalumab may harm the developing fetus. If you are pregnant or planning to become pregnant, discuss with your healthcare provider whether Imfinzi is appropriate for you.
It is unknown whether Durvalumab passes into breast milk. Due to the potential for serious side effects, it is advised to avoid breastfeeding during treatment with Imfinzi. Always consult your doctor before breastfeeding.
Imfinzi 500mg Injection contains Durvalumab, a monoclonal antibody that works by inhibiting the interaction between the PD-L1 protein (present on tumor cells) and the PD-1 receptor (found on T-cells of the immune system). When the PD-L1 protein binds to PD-1, it suppresses the immune system’s ability to attack cancer cells. By blocking this interaction, Durvalumab activates T-cells and enhances the immune system's ability to identify and destroy cancer cells. This helps to shrink tumors and slow cancer progression.
Cancer occurs when abnormal cells grow uncontrollably and spread to other parts of the body. Imfinzi 500mg Injection is used to treat cancers where immune checkpoint inhibitors are effective, such as non-small cell lung cancer (NSCLC) and bladder cancer. NSCLC is the most common type of lung cancer, often requiring advanced treatments like immunotherapy. Urothelial carcinoma, a type of cancer affecting the bladder, can spread to other parts of the urinary tract. Imfinzi works by boosting the immune system’s ability to recognize and attack cancer cells, helping slow disease progression.
Store Imfinzi 500mg Injection in a refrigerator. Keep it in its original carton to protect it from light. Do not freeze the injection. Ensure that it is kept out of reach of children and disposed of according to medical waste guidelines.
Imfinzi 500mg Injection is an advanced cancer treatment designed to enhance the body’s immune system in its fight against certain types of cancer. With the active ingredient Durvalumab, it offers effective treatment for non-small cell lung cancer and urothelial carcinoma, improving survival rates and quality of life. Always follow your healthcare provider’s advice for optimal results.
Content Updated on
Monday, 17 March, 2025Prescription Required
Simplify your healthcare journey with Indian Government's ABHA card. Get your card today!
Create ABHA